InvestorsHub Logo
Followers 8
Posts 923
Boards Moderated 0
Alias Born 10/07/2015

Re: CVR Investor post# 6056

Sunday, 01/31/2021 3:23:45 AM

Sunday, January 31, 2021 3:23:45 AM

Post# of 6072
Okay. Let us know if you succeed to get the CVRs back.

Hopefully TDA will cooperate and we will see a payout in the coming years

"Vincristine Sulfate Liposome Injection Drugs Market Set to Register robust CAGR During 2020-2025"

https://www.groundalerts.com/vincristine-sulfate-liposome-injection-drugs-market

There are recent discussions on using vincristine sulfate for treatment protocol.

"The Food and Drug Administration (FDA) has issued a safety alert regarding the preparation of vinca alkaloids.

According to the Agency, these chemotherapy agents, which include vincristine sulfate injection, vinblastine sulfate injection, and vinorelbine tartrate injection, should only be prepared in intravenous (IV) infusion bags. In order to reduce the potential for unintended intrathecal administration, the FDA is working with manufacturers to update the drug labeling to remove instructions for preparation of these agents by syringe."

https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/vinca-alkaloids-fda-safety-alert-intravenous-infusion-bags-prep/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.